Systematic review with meta-analysis: the risk of gastrointestinal bleeding in patients taking third-generation P2Y12 inhibitors compared with clopidogrel.
Chuan-Guo GuoLijia ChenEsther W ChanKa Shing CheungTakaaki IsshikiIan C K WongWai K LeungPublished in: Alimentary pharmacology & therapeutics (2018)
Third-generation P2Y12 inhibitors were associated with increased risk of GIB and non-CABG major bleeding when compared with clopidogrel.